ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,706.57
      0.33%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Taro Pharmaceutical Industries Ltd (TARO)

      7. Taro Pharmaceutical Industries Ltd (TARO) News

      TARO

      Taro Pharmaceutical Indu... (TARO)

      Taro Pharmaceutical Industries Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:TARO
      DateTimeSourceHeadlineSymbolCompany
      05/23/20248:10AMPR Newswire (US)Taro Shareholders Approve Merger with Sun PharmaNYSE:TAROTaro Pharmaceutical Industries Ltd
      05/23/20248:01AMEdgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
      05/23/20247:50AMPR Newswire (US)Taro Shareholders Approve Merger with Sun PharmaNYSE:TAROTaro Pharmaceutical Industries Ltd
      05/23/20247:50AMPR Newswire (Canada)Taro Shareholders Approve Merger with Sun PharmaNYSE:TAROTaro Pharmaceutical Industries Ltd
      05/23/20247:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
      05/21/20249:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
      05/20/20245:00PMBusiness WireTaro Provides Results for Year Ended March 31, 2024NYSE:TAROTaro Pharmaceutical Industries Ltd
      05/15/20249:00AMBusiness WireTaro to Release Full Year Results on May 20, 2024NYSE:TAROTaro Pharmaceutical Industries Ltd
      05/14/20248:20AMEdgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
      05/08/20249:28AMEdgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
      05/08/20249:07AMBusiness WireLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma MergerNYSE:TAROTaro Pharmaceutical Industries Ltd
      04/15/20248:00AMBusiness WireTaro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.NYSE:TAROTaro Pharmaceutical Industries Ltd
      03/11/20246:19AMEdgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
      02/15/20248:36AMEdgar (US Regulatory)Form SC 13E3 - Going private transaction by certain issuersNYSE:TAROTaro Pharmaceutical Industries Ltd
      01/30/20241:18PMPR Newswire (US)Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law FirmNYSE:TAROTaro Pharmaceutical Industries Ltd
      01/30/20247:00AMPR Newswire (US)Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for TaroNYSE:TAROTaro Pharmaceutical Industries Ltd
      01/26/20249:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
      01/25/20245:06PMBusiness WireTaro Provides Results for December 31, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
      01/19/20244:15PMBusiness WireTaro to Release Third Quarter Results on January 25, 2024NYSE:TAROTaro Pharmaceutical Industries Ltd
      01/17/20244:36PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
      01/17/20244:35PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
      01/17/20244:30PMPR Newswire (US)Taro Announces Merger Agreement with Sun PharmaNYSE:TAROTaro Pharmaceutical Industries Ltd
      01/17/20244:30PMPR Newswire (Canada)Taro Announces Merger Agreement with Sun PharmaNYSE:TAROTaro Pharmaceutical Industries Ltd
      01/04/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
      12/11/20234:31PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
      12/11/20234:30PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
      11/17/20234:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
      10/27/20239:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
      10/26/20235:00PMBusiness WireTaro Provides Results for September 30, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
      10/19/20234:30PMBusiness WireTaro to Release Second Quarter Results on October 26, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
       Showing the most relevant articles for your search:NYSE:TARO

      Your Recent History

      EU
      Q247S
      Q247S
      Delayed Upgrade Clock